Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study

[1]  N. MacDonald,et al.  Preventing ophthalmia neonatorum. , 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[2]  C. O’Donnell,et al.  Unlicensed and off‐label drug use in an Irish neonatal intensive care unit: a prospective cohort study , 2014, Acta paediatrica.

[3]  H. Coelho,et al.  Toxic excipients in medications for neonates in Brazil , 2014, European Journal of Pediatrics.

[4]  J. Anker,et al.  High-dose gentamicin in newborn infants: is it safe? , 2014, European Journal of Pediatrics.

[5]  Åse Sofie Skjerdal,et al.  Institute for Safe Medication Practices (ISMP) , 2013 .

[6]  L. Rey,et al.  A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename). , 2013, Jornal de pediatria.

[7]  L. R. Pereira,et al.  Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA , 2013, International Journal of Clinical Pharmacy.

[8]  M. Danhof,et al.  Developmental pharmacokinetics of propylene glycol in preterm and term neonates. , 2012, British journal of clinical pharmacology.

[9]  K. Allegaert,et al.  Educational paper: Do we need neonatal clinical pharmacologists? , 2013, European Journal of Pediatrics.

[10]  C. G. Carvalho,et al.  Uso de medicamentos off-label e não licenciados em unidade de tratamento intensivo neonatal e sua associação com escores de gravidade , 2012 .

[11]  L. Jain.  The conundrum of off-label and unlicensed drug usage in neonatology. , 2012, Jornal de pediatria.

[12]  R. C. Silveira,et al.  Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores. , 2012, Jornal de pediatria.

[13]  A. B. D. Silva.  SOCIEDADE BRASILEIRA DE PEDIATRIA , 2012 .

[14]  K. Naelapää,et al.  Hospitalised neonates in Estonia commonly receive potentially harmful excipients , 2012, BMC Pediatrics.

[15]  I. Heineck,et al.  Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. , 2012, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

[16]  G. Giacoia,et al.  Drug studies in newborns: a therapeutic imperative. , 2012, Clinics in perinatology.

[17]  C. M. Cotten,et al.  Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. , 2012, Clinics in perinatology.

[18]  F. Manguso,et al.  Ranitidine is Associated With Infections, Necrotizing Enterocolitis, and Fatal Outcome in Newborns , 2012, Pediatrics.

[19]  T. Metsvaht,et al.  Drug utilisation pattern and off-label use of medicines in Estonian neonatal units , 2011, European Journal of Clinical Pharmacology.

[20]  T. Krediet,et al.  Variation in antibiotic use in neonatal intensive care units in the Netherlands. , 2010, The Journal of antimicrobial chemotherapy.

[21]  D. Henderson-smart,et al.  Caffeine versus theophylline for apnea in preterm infants. , 2010, The Cochrane database of systematic reviews.

[22]  T. Leis,et al.  Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis , 2009, European Journal of Clinical Pharmacology.

[23]  C. Giaquinto,et al.  Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. , 2008, Pharmacological research.

[24]  M. Bonati,et al.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil , 2008, European Journal of Clinical Pharmacology.

[25]  Praveen Kumar,et al.  Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. , 2008, The Journal of pediatrics.

[26]  S. Chatterjee,et al.  Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India , 2007, Pharmacoepidemiology and drug safety.

[27]  B. Solarino,et al.  Unlicensed and off-label use of medicines at a neonatology clinic in Italy , 2007, Pharmacy World & Science.

[28]  B. Stoll,et al.  The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants , 2006, Pediatrics.

[29]  G. Natarajan,et al.  Patterns of drug utilization in a neonatal intensive care unit , 2005, Journal of clinical pharmacology.

[30]  T. Stephenson,et al.  Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. , 2005, British journal of clinical pharmacology.

[31]  BMC Pediatrics , 2005 .

[32]  I. Choonara.  Unlicensed and off-label drug use in children: implications for safety. , 2004, Expert opinion on drug safety.